FormWeb • blinatumomab

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

blinatumomab

blinatumomab

Restricted Anti-Neoplastic Formulary
Restricted Blincyto --> Restricted to oncology and admin approval.

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Blincyto	POWDER FOR INJECTION, INTRAVENOUS	35 mcg

Comments:

Blincyto medication guide

If requested for an inpatient, submit to pharmacy administration for case by case evaluation.

Reviewed: April 28, 2015

REMS: View FDA REMS Info

Last updated: Apr. 11, 2024

Black Box Warning: Cytokine Release Syndrome and Neurological Toxities
HAZ-MED: Group 2
Chemotherapy:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.